Zobrazeno 1 - 10
of 10
pro vyhledávání: '"YA‑QIANG HUANG"'
Autor:
YA‑QIANG HUANG1,2, XIAO‑HUI LING3, RUN‑QIANG YUAN1, ZHI‑YUN CHEN3, SHENG‑BANG YANG4, HONG‑XING HUANG1 hhxzs@21cn.com, WEI‑DE ZHONG4 zhongwd2009@live.cn, SHAO‑PENG QIU2
Publikováno v:
Molecular Medicine Reports. Sep2017, Vol. 16 Issue 3, p2431-2438. 8p.
Autor:
Zhuo-yuan Lin, Zhao-Dong Han, Funeng Jiang, Wei-de Zhong, Ya-Qiang Huang, Xiao-hui Ling, Jia-Hong Chen, Chao Cai, Yanqiong Zhang, Yu-Xiang Liang, Fen Wang, Qi-shan Dai, Xin Fu, Hui-chan He, Chin-Lee Wu
Publikováno v:
International Journal of Cancer. 135:541-550
Our previous microarray data showed that microRNA-224 (miR-224) was downregulated in human prostate cancer (PCa) tissues compared with adjacent benign tissues. However, the underlying mechanisms by which miR-224 is involved in PCa remain unclear. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0db3282743907978e900b523b0f8ebc7
https://doi.org/10.1002/ijc.28707
https://doi.org/10.1002/ijc.28707
Autor:
Ya‑Qiang Huang, Hong‑Xing Huang, Xiao‑Hui Ling, Wei-de Zhong, Run‑Qiang Yuan, Sheng‑Bang Yang, Shao‑Peng Qiu, Zhi‑Yun Chen
Publikováno v:
Molecular Medicine Reports
Our previous study revealed that microRNA (miR) ‑30c represents a potential tumor suppressor gene, the expression of which is associated with decreased oncogenic potential in prostate cancer (PCa) cell lines. However, the functional role and underl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80ef3d96228ecced310ec22448760dd8
https://pubmed.ncbi.nlm.nih.gov/28677791
https://pubmed.ncbi.nlm.nih.gov/28677791
Autor:
Cong Wang, Chao Cai, Zhao-Dong Han, Jun Zou, Ya-Qiang Huang, Funeng Jiang, Hui-chan He, Yu-Xiang Liang, Liang Zhou, Hong-Wei Luo, Wei-de Zhong
Publikováno v:
Medical Oncology. 32
Novel molecular markers for cancer progression are valuable for the diagnosis and evaluation of treatment efficacies of the diseases. Expression of inosine 5'-monophosphate dehydrogenase type II (IMPDH2), a rate-limiting enzyme in the de novo guanine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6914830a1c76e8df3a0a64586a1633
https://doi.org/10.1007/s12032-014-0373-1
https://doi.org/10.1007/s12032-014-0373-1
Publikováno v:
American journal of clinical and experimental urology. 2(4)
Prostate-specific antigen (PSA) has been widely used as a serum marker for prostate cancer (PCa) screening or progression monitoring, which dramatically increased rate of early detection while significantly reduced PCa-specific mortality. However, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::937b9f1e8d1486610c6b7532929d8bc9
https://pubmed.ncbi.nlm.nih.gov/25606581
https://pubmed.ncbi.nlm.nih.gov/25606581
Autor:
Wei-de Zhong, Funeng Jiang, Hao Fu, Ya-Qiang Huang, Hui-chan He, Yue-Ping Wan, Zhao-Dong Han, Yu-Xiang Liang, Qi-shan Dai, Chao Cai, Hong-Wei Luo
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 36(3)
We previously demonstrated that microRNA (miR)-224 expression was significantly reduced in human prostate cancer (PCa) tissues and predicted unfavorable prognosis in patients. However, the underlying mechanisms of miR-224 have not been fully elucidat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8070ea95177695926365d5530f30b2cf
https://pubmed.ncbi.nlm.nih.gov/25394900
https://pubmed.ncbi.nlm.nih.gov/25394900
Autor:
Guo-qiang Qin, Funeng Jiang, Jie-xian Li, Hao Fu, Liang Zhou, Yu-Xiang Liang, Hui-chan He, Ya-Qiang Huang, Sheng-bang Yang, Zhao-Dong Han, Wei-de Zhong
Publikováno v:
OncoTargets and therapy
Guo-qiang Qin,1,2,* Hui-chan He,2,* Zhao-dong Han,2,* Yu-xiang Liang,2 Sheng-bang Yang,2 Ya-qiang Huang,2 Liang Zhou,2 Hao Fu,2 Jie-xian Li,1,2 Fu-neng Jiang,2 Wei-de Zhong2–4 1Central Hospital of Panyu District, Guangzhou, People's Republic of Chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e54e785d0c705f6b4a22e2e028ae0942
https://www.dovepress.com/combined-overexpression-of-hivep3-and-sox9-predicts-unfavorable-bioche-peer-reviewed-article-OTT
https://www.dovepress.com/combined-overexpression-of-hivep3-and-sox9-predicts-unfavorable-bioche-peer-reviewed-article-OTT
Autor:
Jia-Hong Chen, Zhuo-yuan Lin, Xiao-hui Ling, Zhao-Dong Han, Yan-Ru Chen, Xin Fu, Hui-chan He, Yu-Xiang Liang, Chao Cai, Ya-Qiang Huang, Qi-shan Dai, Xue-cheng Bi, Wei-de Zhong, Funeng Jiang
Publikováno v:
Medical oncology (Northwood, London, England). 31(1)
The aim of this study was to investigate the associations of myosin light chain (MYL9) downregulation with tumor progression and prognosis in patients with prostate cancer (PCa). MYL9 protein expression in human PCa and non-cancerous prostate tissues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b11555b25eb9d6039477c7e59fcd4cac
https://pubmed.ncbi.nlm.nih.gov/24338276
https://pubmed.ncbi.nlm.nih.gov/24338276
Autor:
Zhuo-Yuan, Lin, Ya-Qiang, Huang, Yan-Qiong, Zhang, Zhao-Dong, Han, Hui-Chan, He, Xiao-Hui, Ling, Xin, Fu, Qi-Shan, Dai, Chao, Cai, Jia-Hong, Chen, Yu-Xiang, Liang, Fu-Neng, Jiang, Wei-De, Zhong, Fen, Wang, Chin-Lee, Wu
Publikováno v:
International journal of cancer. 135(3)
Our previous microarray data showed that microRNA-224 (miR-224) was downregulated in human prostate cancer (PCa) tissues compared with adjacent benign tissues. However, the underlying mechanisms by which miR-224 is involved in PCa remain unclear. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::379af602db7c6ea9d8fb4a4078840f7b
https://pubmed.ncbi.nlm.nih.gov/24382668
https://pubmed.ncbi.nlm.nih.gov/24382668
Autor:
Yan-Ru Zeng, Zhao-Dong Han, Cong Wang, Chao Cai, Ya-Qiang Huang, Hong-Wei Luo, Ze-Zhen Liu, Yang-Jia Zhuo, Qi-Shan Dai, Hai-Bo Zhao, Yu-Xiang Liang, Wei-De Zhong
Publikováno v:
BMC Urology; Aug2015, Vol. 15 Issue 1, p1-8, 8p